Retraction to: Cancer Gene Therapy https://doi.org/10.1038/s41417-024-00801-8, published online 22 July 2024
The Editor-in-Chief has retracted this article because of concerns regarding the figures presented in this work. These concerns call into question the article’s overall scientific soundness. An investigation conducted after its publication discovered the following issues:
-
the p53/SHG-44 gel slice in Figure 3G appears to overlap with the the p53/SHG-44 gel slice in Figure 3H;
-
the GADPH/SHG-44 gel slice in Figure 3G appears to overlap with the the GADPH/SHG-44 gel slice in Figure 3H;
-
the x400 magnification panels in the KI67 row of Figure 6D are different from those shown at a lower magnification.
The Editor-in-Chief therefore no longer has confidence in the integrity of the research presented in this article.
The authors have agreed with this retraction, but not the wording of this retraction notice.
Author information
Authors and Affiliations
Corresponding author
About this article
Cite this article
Chen, R., Chen, H. & Hu, C. Retraction Note: HADHA promotes glioma progression by accelerating MDM2-mediated p53 ubiquitination. Cancer Gene Ther 32, 912 (2025). https://doi.org/10.1038/s41417-025-00924-6
Published:
Issue date:
DOI: https://doi.org/10.1038/s41417-025-00924-6